Table 2. EtD for EML decision-criteria, descriptions and judgements.
| EtD for EML Criteria | Description | Judgements |
|---|---|---|
| Public Health Relevance | Is the medicine being evaluated for a condition of important public health relevance? | • No • Probably No • Probably Yes • Yes • Varies (if so, why?) • Don’t know |
| Values | Is there important uncertainty in how people value the main outcomes? | • Important Uncertainty • Possibly important uncertainty • Probably no important uncertainty • No important uncertainty |
| Benefits (desirable effects) | How substantial are the benefits? | • Trivial • Small • Moderate • Large • Varies (if so, why?) • Don’t know |
| Harms and toxicity (undesirable effects) | How substantial are the harms and toxicity? | • Trivial • Small • Moderate • Large • Varies (if so, why?) • Don’t know |
| Certainty of evidence | What is the overall certainty of the evidence of effects? | • Very Low • Low • Moderate • High • No included studies |
| Does the balance of effects favour the medicine being considered an essential medicine? | • No • Probably No • Probably Yes • Yes • Varies (if so, why?) • Don’t know |
|
| Resources required (costs) | How large are the resources required (costs) | • Large costs • Moderate costs • Negligible costs and savings • Moderate savings • Large savings • Varies (if so, why?) • Don’t know |
| Cost effectiveness | Does the cost-effectiveness favour the medicine? | • Favours the medicine • Probably favours the medicine • Does not favour either the medicine or no medicine • Probably does not favour the medicine • Does not favour the medicine • Varies (if so, why?) • Don’t know |
| Equity | What would the impact of listing the medicine be on health equity? | • Reduced • Probably reduced • Probably increased • Increased • Varies (if so, why?) • Don’t know |
| Acceptability | Is the medicine acceptable to key stakeholders? | • No • Probably No • Probably Yes • Yes • Varies (if so, why?) • Don’t know |
| Feasibility | Is the medicine feasible to implement? | • No • Probably No • Probably Yes • Yes • Varies (if so, why?) • Don’t know |
| Availability | What is the regulatory status, market availability and on-the-ground availability/access of the medicine to patients? |
• Not available in most settings • Probably not available in most settings • Probably available in most settings • Available in most settings • Varies (if so, why?) • Don’t know |
| Decision | Should this medicine be on the EML? |
• Yes, list the medicine • No, do not list the medicine • Remove the medicine (if already on the list) • List the medicine under certain conditions (list conditions) |